drugset / Trial / NCT07476586
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult Participants
RandomizedParallel-groupQuadruple-blindOther
Summary
To Evaluate the Safety and Tolerability, Pharmacokinetics and Biomarker of GenSci161 in a Randomized, Double-blind, Placebo-controlled Study in Healthy Adult Participants.
Timeline
- Start
- 2026-04-20
- Primary completion
- 2027-05-06
- Completion
- 2027-08-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GenSci161 | Unknown | — | Subcutaneous |
Indications
No indication recorded.